Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157 L-NAME and L-arginine
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper)
Across preclinical studies, Epitalon has shown: Telomerase activation and telomere extension: Via TRAP assays and fibroblast lifespan extension beyond the Hayflick limit Epigenetic remodeling: Reversal of chromatin aging, histone modulation, and gene promoter binding Redox homeostasis: Increased antioxidant enzymes (SOD, NQO1, catalase) and reduced ROS, lipid peroxidation, and DNA damage Circadian restoration: Upregulation of AANAT/pCREB, normalized melatonin and cortisol rhythms, and clock gene modulation in humans Cancer risk reduction: Reduced tumor multiplicity and delayed onset in HER-2/neu and colon cancer models
This covers sending your prescription as well as ongoing support from your provider and our team throughout your treatment
BPC-157 = 10 mg 30 = 0.33 mg
GHK-Cu and PRP share some mechanistic overlap both promote growth factor activity and tissue remodeling at the follicle level